ABSTRACT & COMMENTARY

Adverse Effects of Electronic Cigarettes on the Disease-Naïve Oral Microbiome

Name: Relias Media
Price range: $

January 30, 2022

A robust metagenomic comparison study of the effects of electronic cigarettes on oral microbiomes suggested that the unique aerosol component of electronic cigarettes poses increased risk to development of oral cavity disease.

Issue Date: January 30, 2022

Table of Contents

Financial Disclosure: Dr. Stephen Brunton, physician editor, reports he is on the speakers bureau for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk and is a retained consultant for Abbott Diabetes Care, AstraZeneca, Bayer, GSK, and Novo Nordisk. Dr. Rebecca H. Allen, author, reports she receives grant/research support from Bayer and is a consultant for Bayer, Mylan, and Merck. The relevant financial relationships listed have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements